Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes-Reference-Cited by-同舟云学术

Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes

Published:2022-04-18 Issue:4 Volume:5 Page:e227705
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Kianmehr Hamed¹,Zhang Ping²,Luo Jing³,Guo Jingchuan¹⁴,Pavkov Meda E.²,Bullard Kai McKeever²,Gregg Edward W.⁵,Ospina Naykky Singh⁶,Fonseca Vivian⁷,Shi Lizheng⁸,Shao Hui¹²⁴

Affiliation:

1. Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville

2. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia

3. Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

4. Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville

5. School of Public Health, Imperial College London, London, United Kingdom

6. Division of Endocrinology, Diabetes, and Metabolism, University of Florida College of Medicine, Gainesville

7. Department of Medicine and Pharmacology, School of Medicine, Tulane University, New Orleans, Louisiana

8. Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2791200/kianmehr_2022_oi_220242_1649453574.65092.pdf

Reference39 articles.

1. Risk of cause-specific death in individuals with diabetes: a competing risks analysis.;Baena-Díez;Diabetes Care,2016

2. Diabetes mellitus, fasting glucose, and risk of cause-specific death.;Rao Kondapally Seshasai;N Engl J Med,2011

3. Development of life-expectancy tables for people with type 2 diabetes.;Leal;Eur Heart J,2009

4. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.;Ting;Clin Exp Ophthalmol,2016

5. A healthy bottom line: healthy life expectancy as an outcome measure for health improvement efforts.;Stiefel;Milbank Q,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis;Atherosclerosis;2024-09

2. All‐cause and cause‐specific mortality risk and loss in life expectancy associated with incident type 2 diabetes onset age and duration;Journal of Internal Medicine;2024-07-18

3. Monitoring Global Progress in Core Diabetes Control Metrics: Protocol for a Systematic Review of Prevalence (2015–2023);HRB Open Research;2024-04-29

4. Glycemic homeostasis of ultrasound-assisted Murraya koenigii (Linn.) Spreng. bark extract in streptozocin-induced diabetes in rats;Journal of Umm Al-Qura University for Applied Sciences;2024-04-06

5. Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease;Pharmaceuticals;2024-03-26